Back to the future: lessons from development drive innovation of human pluripotent stem cell therapies

Andrea Ditadi; Christopher M. Sturgeon

doi:10.1016/j.exphem.2022.11.003

Back to the future: lessons from development drive innovation of human pluripotent stem cell therapies

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	9-14
Number of pages	6
Journal	Experimental Hematology
Volume	117
DOIs	https://doi.org/10.1016/j.exphem.2022.11.003
State	Published - Jan 2023

Access to Document

10.1016/j.exphem.2022.11.003

Cite this

@article{2bf756036d244137b03da04648a6b602,

title = "Back to the future: lessons from development drive innovation of human pluripotent stem cell therapies",

author = "Andrea Ditadi and Sturgeon, {Christopher M.}",

note = "Funding Information: The names of the speakers are as follows, in the order they presented during the meeting: Gordon Keller (McEwen Stem Cell Institute, Toronto, Canada), Andrew Elefanty (Murdoch Childrens Institute, Melbourne, Australia), Hanna Mikkola (University of California, Los Angeles, CA, US), Brandon Hadland (Fred Hutchinson Cancer Research Center, Seattle, WA, US), Andrea Ditadi (San Raffaele Telethon Institute for Gene Therapy, Milan, Italy), Eirini Papapetrou (Mount Sinai School of Medicine, New York, NY, US), Grant Rowe (Dana-Farber Cancer Institute, Boston, MA, US), Sergei Doulatov (University of Washington, Seattle, WA, US), Minji Byun (University of California, Irvine, CA, US), Martina Sarchi (University of Washington, Seattle, WA, US), Christopher Sturgeon (Mount Sinai School of Medicine, New York, NY, US), Dan Kaufman (University of California, San Diego, CA, US), Igor Slukvin (University of Wisconsin - Madison, WI, US), Ran Jing (Boston Children's Hospital), Sjoukje Van Der Stegen (Memorial Sloan Kettering Institute, New York, US), and Ross Jones (University of British Columbia, Vancouver, Canada). We also wish to acknowledge Astellas, Fate Therapeutics, Sana Biotechnology, Regeneron, Megakaryon, and Stem Cell Technologies for sponsorship of this meeting.",

year = "2023",

month = jan,

doi = "10.1016/j.exphem.2022.11.003",

language = "English",

volume = "117",

pages = "9--14",

journal = "Experimental Hematology",

issn = "0301-472X",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Back to the future

T2 - lessons from development drive innovation of human pluripotent stem cell therapies

AU - Ditadi, Andrea

AU - Sturgeon, Christopher M.

N1 - Funding Information: The names of the speakers are as follows, in the order they presented during the meeting: Gordon Keller (McEwen Stem Cell Institute, Toronto, Canada), Andrew Elefanty (Murdoch Childrens Institute, Melbourne, Australia), Hanna Mikkola (University of California, Los Angeles, CA, US), Brandon Hadland (Fred Hutchinson Cancer Research Center, Seattle, WA, US), Andrea Ditadi (San Raffaele Telethon Institute for Gene Therapy, Milan, Italy), Eirini Papapetrou (Mount Sinai School of Medicine, New York, NY, US), Grant Rowe (Dana-Farber Cancer Institute, Boston, MA, US), Sergei Doulatov (University of Washington, Seattle, WA, US), Minji Byun (University of California, Irvine, CA, US), Martina Sarchi (University of Washington, Seattle, WA, US), Christopher Sturgeon (Mount Sinai School of Medicine, New York, NY, US), Dan Kaufman (University of California, San Diego, CA, US), Igor Slukvin (University of Wisconsin - Madison, WI, US), Ran Jing (Boston Children's Hospital), Sjoukje Van Der Stegen (Memorial Sloan Kettering Institute, New York, US), and Ross Jones (University of British Columbia, Vancouver, Canada). We also wish to acknowledge Astellas, Fate Therapeutics, Sana Biotechnology, Regeneron, Megakaryon, and Stem Cell Technologies for sponsorship of this meeting.

PY - 2023/1

Y1 - 2023/1

UR - http://www.scopus.com/inward/record.url?scp=85144038683&partnerID=8YFLogxK

U2 - 10.1016/j.exphem.2022.11.003

DO - 10.1016/j.exphem.2022.11.003

M3 - Review article

C2 - 36400313

AN - SCOPUS:85144038683

SN - 0301-472X

VL - 117

SP - 9

EP - 14

JO - Experimental Hematology

JF - Experimental Hematology

ER -